C&R Research (XKRX:359090) Current Accrued Expense : ₩0 Mil (As of Jun. 2024)

View and export this data going back to 2020. Start your Free Trial

What is C&R Research Current Accrued Expense?

C&R Research's Current Accrued Expense for the quarter that ended in Jun. 2024 was ₩0 Mil.

C&R Research Current Accrued Expense Historical Data

The historical data trend for C&R Research's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C&R Research Current Accrued Expense Chart

C&R Research Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Current Accrued Expense

C&R Research Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Current Accrued Expense	Get a 7-Day Free Trial												-	-	-	-	-

C&R Research Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

C&R Research Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of C&R Research's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

C&R Research Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » C&R Research Inc (XKRX:359090) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

412 Yeoksam-ro, C&R Building, Gangnam-gu, Seoul, KOR

Website

http://www.cnrres.com

C&R Research Inc provides a quotation on clinical trial service.

C&R Research Headlines

No Headlines